In this video, Erik Lemay, Head of Global External manufacturing at Servier discusses the manufacture of L-asparaginase, the active pharmaceutical ingredient for Servier’s Acute Lymphoblastic Leukemia (ALL) therapies, and how its collaboration with Lonza has delivered a manufacturing process that gives a 20% improvement in product yield.
Watch this video

Watch now
Latest content
Latest briefing from the Knowledge Center